Cepsa

Photo
30.10.2024 • News

CEPSA Becomes Moeve

Today, CEPSA announced its name change to Moeve, marking a historic milestone in the company’s transformation. This change positions Moeve as a leader in the European energy transition and demonstrates the significant progress achieved under its 2030 Positive Motion strategy, reinforcing its full commitment to sustainable energy and mobility.

Photo
12.06.2024 • News

CEPSA Begins Construction of an Isopropyl Alcohol Plant in Spain

CEPSA has begun constructing a plant to produce 80,000 mt of isopropyl alcohol in Spain. The new facility represents an investment of € 75 million. The facility will be able to replace fossil-based raw materials with sustainable materials, thereby reinforcing CEPSA's Positive Motion strategy to drive the energy transition.

Photo
24.02.2023 • News

CEPSA and Fertiberia Partner on Hydrogen in Huelva

Spanish companies CEPSA and Fertiberia – two of the country’s largest hydrogen consumers – have agreed to jointly develop a large-scale green hydrogen plant in Huelva, decarbonizing both their production processes.

Photo
16.11.2022 • News

Sinarmas CEPSA Expands Bio-based Chemicals

Sinarmas CEPSA, a 50:50 joint venture between Spanish CEPSA and Indonesian conglomerate Sinar Mas, has signed a Memorandum of Understanding (MoU) with Singaporean palm oil producer Golden Agri-Resources – a subsidiary of Sinar Mas – to expand bio-based chemicals production.

Photo
12.07.2022 • News

Petrobras Closes Deten Sale to CEPSA

Brazilian oil group Petrobras has finalized the sale of its entire 27.88% stake in linear alkyl benzene (LAB) producer Deten Quimica to Spanish energy and petrochemicals group CEPSA Quimica for 514 million Brazilian reais.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.